Background
==========

Various species of genera like *Clostridium*, *Escherichia*, *Listeria*, *Salmonella, Shigella, Staphylococcus* and *Vibrio*\[[@B1],[@B2]\] are known to cause food spoilage. In addition, different drug resistant strains of *Escherichia* and *Salmonella* belonging to family *Enterobacteriaceae* are reported to cause food-borne illness \[[@B3]-[@B6]\]. Increasing multidrug-resistance in bacteria resulted in a greater need to find alternative antimicrobial substances that can be used for various applications including clinical as well as preservation of food and dairy products. Therefore, research on antimicrobial peptides including antimicrobial biosurfactants as a new class of drugs has increased in the recent past as they exhibit both narrow and broad spectrum inhibition activities against Gram-positive and Gram-negative bacteria or fungi. Although members of the *Enterobacteriaceae* family are known to produce bacteriocins such as enterocins by *Enterobacter* sp. \[[@B7]\], serracin by *Serratia* sp. \[[@B8]\] bacteriocin by *Citrobacter* sp. \[[@B9]\] and microcins by *Escherichia* sp. \[[@B10]\], they are not reported to produce any antimicrobial biosurfactants. The different types of biosurfactants with antimicrobial activity include lipopeptides, glycolipids, phospholipids and lipopolysaccharides \[[@B11]\]. While many Gram-positive bacteria including different species of the genus *Bacillus* are reported to produce diverse antimicrobial lipopeptides with different applications in pharmaceutical and food processing industries \[[@B12]\], only few lipopeptides have been reported to produce by Gram-negative bacteria like *Pseudomonas*\[[@B13]\]. The lipopeptides produced by Gram-positive strains have been classified into various types based on their amino acid composition and fatty acid chain length \[[@B14]\]. Similarly, lipopeptides of *Pseudomonas* also have been grouped into different groups including amphisin, syringomycin, tolaasin and viscosin based on the number and composition of amino acids \[[@B13],[@B15],[@B16]\]. Among the several types of biosurfactants, lipopeptides belonging to iturins \[[@B17]\], surfactins, \[[@B18]\], fengycins \[[@B19]\], kurstakins \[[@B20]\], bacillomycins \[[@B21]\] and mycosubtilin \[[@B22]\] displayed therapeutic applications \[[@B23]\] and they were never reported to produce by any Gram-negative bacteria. Therefore, in the present study we have isolated few Gram-negative bacterial strains belonging to genera *Citrobacter* and *Enterobacter* producing antimicrobial lipopeptides from a fecal contaminated soil sample. Further, detailed characterization of these antimicrobial lipopeptides assigned them to iturins, fengycins, kurstakins and surfactins, usually produced by Gram-positive bacteria.

Results
=======

Identification of the lipopeptide producing strains
---------------------------------------------------

Nine antimicrobial producing strains were isolated from a fecal contaminated soil sample during a screen to isolate the bacteriocin producing bacteria. The colonies were selected based on colony morphology and the zone of clearance in their surroundings that might be formed due to the activity of antimicrobial substances produced by the strain (Figure [1](#F1){ref-type="fig"}A). The isolates grew well on tryptone soya agar (TSA) between pH 5.0 to 9.0 and up to 42°C temperature with optimum growth at 37°C. All strains were rod shaped, facultative anaerobes, showed positive reaction to catalase and negative for oxidase activities. The 16S rRNA gene sequence BLAST analysis revealed high identity with *Citrobacter farmeri* for strains S-3, S-6 and S-7. Other strains including S-4, S-5 and S-9 had identity with different species of the genus *Enterobacter*. Strains S-10, S-11 and S-12 showed high similarity with *E. cloacae* subsp. *dissolvens*. Further, Phylogenetic analysis with close relatives also assigned them to genera *Citrobacter* and *Enterobacter* of the family *Enterobacteriaceae*. In neighbour-joining phylogenetic tree, strains S-3, S-6 and S-7 formed a cluster with *C. farmeri* and *C. amalonaticus* (Figure [2](#F2){ref-type="fig"}). Although isolate S-9 showed 98.1% identity with *E. mori* in 16S rRNA gene blast analysis, it formed an out group to the clade containing *E. hormaechei* and *E. mori* with low bootstrap value. Overall, most of the clusters of the neighbour-joining phylogenetic tree showed low bootstrap values.

![**Screening of isolates for antimicrobial activity. (A)** colonies showing zone of clearance **(B)** well diffusion assay of methanol extracts. Selected colonies were purified and preserved. Further, methanol extracts were prepared from 48 h cell free fermented broth of all selected isolates and tested against *S. aureus* (MTCC1430).](1471-2180-13-152-1){#F1}

![**Neighbour-joining phylogenetic tree of 16S rRNA gene sequences of all strains showing the relationship with members of the genera*Citrobacter*and*Enterobacter*.** The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree.](1471-2180-13-152-2){#F2}

Isolation and antimicrobial activity of lipopeptides
----------------------------------------------------

The methanol extracts of lipopeptides obtained from different strains (mentioned as sample S-3 to S-12) were tested for antimicrobial activity using *Staphylococcus aureus* (MTCC1430) as test strain (Figure [1](#F1){ref-type="fig"}B) and subsequently purified using RP-HPLC. Methanol extract of each sample showed multiple peaks during their HPLC analysis and the number of peaks differed for individual strain. The extract obtained from strain S-3 yielded a maximum number of six peaks followed by strains S-11 and S-5. Individual lipopeptides (fractions) collected from extracts of different strains were purified and used to find their antimicrobial activity against Gram-positive and Gram-negative test strains. Though, *S. epidermidis* (MTCC435) and *Pseudomonas aeruginosa* (ATCC27853) were taken as representative Gram-positive and Gram-negative indicator strains initially, subsequently antimicrobial activity was tested against *S. aureus*, *Micrococcus luteus* (MTCC106) and *Candida albicans* (MTCC1637). Majority of fractions showed activity towards Gram-positive indicator strains (Figure [3](#F3){ref-type="fig"}A) and variations observed in relative sensitivity of Gram-negative test strain towards different antimicrobial lipopeptide fractions (Figure [3](#F3){ref-type="fig"}B). Overall, lipopeptide fractions obtained from strains S-3 and S-11 showed highest activity against test strains. In particular, fractions Fr-c and Fr-e of strain S-11 exhibited maximum antimicrobial activity against *S. aureus* and *M. luteus* at lower concentrations by inhibiting the complete growth, however, none of the lipopeptides inhibited the growth of yeast like *C. albicans* (data not shown).

![**Determination of antibacterial property of lipopeptide fractions.** The assay performed against Gram positive *S. epidermidis***(A)** and Gram negative *P. aeruginosa***(B)** bacteria. Data are the means calculated from three replicate experiments and vertical bars correspond to standard deviations. Asterisk represents significant differences between treatments and negative control (0) with p\<0.005 using one-way ANOVA followed by Dunnett's test. The results are presented as the mean of triplicates (n=3) ± SD.](1471-2180-13-152-3){#F3}

Determination of minimum inhibitory concentration (MIC) and sensitivity
-----------------------------------------------------------------------

The MIC analysis of purified lipopeptide fraction Fr-c of strain S-11 revealed 12, 15 and 16 μg/ml concentration for Gram-positive test strains *M. luteus*, *S. aureus* and *S. epidermidis*, respectively. In contrast, Gram-negative test strains like *Serratia marcescens* and *P. aeruginosa* exhibited MIC of 20 and 32 μg/ml respectively. Results of heat stability assay of these lipopeptides fractions revealed no reduction in activity even after exposing to temperature of 100°C for 30 min (data not shown).

Mass spectrometry characterization of lipopeptides
--------------------------------------------------

The HPLC purified individual lipopeptide fractions were collected, confirmed their purity by reinjection into HPLC and used for the structure determination by MALDI-TOF mass spectrometry. Results of analysis of all HPLC fractions revealed the presence of various lipopeptide species. The mass ion with m/z 984/985 Da was observed in fractions of lipopeptides produced by all strains (Table [1](#T1){ref-type="table"}) and the GC MS analysis for fatty acid identification suggested that it had a β-hydroxylated C~15~ fatty acid. Additional GC-MS analysis of all HPLC purified fractions documented the presence of β-hydroxy fatty acid with a chain length from C~7~ to C~17~. The fractions Fr-c and Fr-e found commonly in strains S-3 and S-11 showed high antimicrobial activity and the molecular mass determined for these lipopeptides were m/z 1495 and 1065, respectively (Figure [4](#F4){ref-type="fig"}). The fatty acid analysis revealed that fractions Fr-c and Fr-e contained β-hydroxy fatty acids with chain lengths C~17~ and C~14~ respectively, suggesting that these compounds belong to the antimicrobial lipopeptide family fengycin and iturin respectively. Further, the amino acid sequence obtained for the fraction Fr-c (EOrnYTEVPEYV) confirmed it as a member of fengycin family. The molecular mass and fatty acid composition of fraction with m/z 1043 (Fr-a of sample S-6) assigned it to lipopeptide group surfactin. Other antimicrobial mass ions produced by these strains include m/z 607, 637, 679, 721, 746, 1153, 1180, 1522 and 1535.

![MALDI MS spectrum of Fr-c and Fr-e from strainS-3 (identical spectrum is observed with the Fr-c and Fr-e of the strain S-11).](1471-2180-13-152-4){#F4}

###### 

List of masses observed in fractionated lipopeptides from different samples obtained in positive ion linear mode

   **Sample name**   **HPLC fraction number**   **Mass (m/z)**   **SD**
  ----------------- -------------------------- ---------------- --------
     Sample S-3                Fr-a                 985.13       0.0021
        Fr-b                  985.73                0.0037      
        Fr-c                 1495.11                0.0069      
        Fr-d                 1522.52                0.003       
        Fr-e                 1065.22                0.0034      
        Fr-f                  607.21                 0.01       
     Sample S-4                Fr-a                 679.57       0.0052
        Fr-b                  984.82                 0.01       
     Sample S-5                Fr-a                 679.69       0.0092
        Fr-b                  984.77                 0.01       
        Fr-c                  637.06                 0.05       
        Fr-d                  746.17                0.0042      
     Sample S-6                Fr-a                1043.66        0.01
        Fr-b                  984.96                0.0059      
        Fr-c                  637.01                0.0071      
     Sample S-7                Fr-a                1180.01       0.022
        Fr-b                  985.01                0.015       
        Fr-c                  721.25                0.0011      
     Sample S-9                Fr-a                1536.16       0.0092
        Fr-b                  984.57                 0.01       
     Sample S-10               Fr-a                1535.21       0.0074
        Fr-b                  984.21                0.0098      
     Sample S-11               Fr-a                1153.65       0.0075
        Fr-b                  984.22                0.0012      
        Fr-c                 1495.43                0.0045      
        Fr-d                  637.23                0.025       
        Fr-e                 1065.21                 0.01       
     Sample S-12               Fr-a                 679.23       0.003
                               Fr-b                 984.14       0.0091

The calculations of standard deviation (SD) were done using MS Excel Descriptive Statistics for each ion measurements (n=4), mi is the measured mass and following is the formula: $\sqrt{\frac{{\sum_{f}\left( {m_{1} - {\overline{m}}_{1}} \right)}^{2}}{n - 1}}$.

Discussion
==========

Several reports have described that soil microbes are worthy to be used as the source of different antimicrobial substances including peptides for versatile applications \[[@B24]\]. Most of the antimicrobial peptides produced by diverse bacteria inhibit Gram-positive strains like *Listeria monocytogens* but not Gram-negative \[[@B25]\]. Among the various peptides, lipopeptides are well known to inhibit the growth of fungi and bacteria including opportunistic pathogens. Consequently, naturally produced antimicrobial lipopeptides have been receiving increased attention due to their anti-infective nature with wide antimicrobial spectrum. Besides the activity of natural peptides, any chemical modifications in structure of these lipopeptide are shown to improve their spectrum and activity. To this effect, daptomycin, an anionic lipopeptide has already been used for therapeutic applications \[[@B26]\]. While antimicrobial lipopeptides are produced by different Gram-positive and Gram-negative bacteria, only lipopeptides produced by species of *Pseudomonas* and *Bacillus* have been studied in detail \[[@B13],[@B14],[@B27]-[@B29]\]. In the present study several antimicrobial substances producing bacterial strains were isolated from a fecal contaminated soil sample and characterization of these substances revealed them as antimicrobial lipopeptides.

The phenotypic features like Gram-negative staining, catalase positive, oxidase negative, facultative anaerobic growth and citrate utilization observed for all strains suggested that they belong to the *Enterobacteriaceae* family, usually observed in fecal matter. The 16S rRNA gene sequence blast analysis and subsequent phylogentic analysis assigned all strains to different species of the genera *Citrobacter* and *Enterobacter*. Interestingly, though strains S-5 and S-9 displayed high identity with *E. hormaechei* and *E. mori* respectively in 16S rRNA gene sequence, they only formed an out group to the cluster comprised of different *Enterobacter* and *Citrobacter* species (Figure [2](#F2){ref-type="fig"}). However, the overall topology of neighbour-joining tree revealed the phylogenetic complexity and discrepancies in 16S rRNA gene sequences of strains belonging to the family *Enterobacteriaceae*. It was also supported by the unusual inclusion of different species belonging to genera *Citrobacter* and *Enterobacter* in the same cluster suggesting the need to revisit the family *Enterobacteriaceae*.

The antimicrobial lipopeptides typically contain a cyclic or linear oligopeptide linked with a β-hydroxy fatty acid tail of varied lengths \[[@B28]\]. Inhibition spectra of these lipopeptides are influenced by the composition of oligopeptide as well as fatty acid component \[[@B30],[@B31]\]. Antimicrobial lipopeptides are largely produced by Gram-positive bacteria like *Bacillus* sp. and are classified into different families based on the composition of oligopeptides and antibacterial or antifungal activities \[[@B32]\]. Among the Gram-negative bacteria, *Pseudomonas* is the only genus reported to produce antimicrobial lipopeptides such as massetolide, viscosin \[[@B33]\], syringomycin \[[@B34]\], arthrofactin \[[@B35]\], pseudodesmins \[[@B36]\], orfamide \[[@B16]\] and putisolvin \[[@B37]\]. In addition to these lipopeptides, species like *P. fluorescens* was reported to produce different massetolide analogues \[[@B33]\]. However, lipopeptides produced by Gram-positive or Gram-negative bacteria had different composition and so far no bacterial strain has been reported to produce reciprocal combinations of lipopeptide composition. Therefore, in the present study we made an attempt to characterize lipopeptides produced by the strains of genera *Citrobacter* and *Enterobacter*.

The comprehensive mass spectral (MALDI-TOF MS and GC-MS) analysis of HPLC purified antimicrobial lipopeptides obtained from strains of *Citrobacter* and *Enterobacter* revealed the occurrence of different lipopeptide antibiotics belonging to groups like kurstakin, iturin, surfactin and fengycin, usually produced by Gram-positive bacteria. Further, individual lipopeptide belonging to a particular group shown to exhibit differences in their amino acids \[[@B13],[@B27]\], fatty acid chain length or isomers of fatty acids and thus generating various analogues with varied activity \[[@B13],[@B33]\]. Accordingly, lipopeptides of the present study showed differences in fatty acid composition and also differed in their antibacterial activity. Of the various lipopeptides, the lipopeptide fraction Fr-b produced by all strains had a molecular weight of 984/985 Da. Although amino acid composition of this peptide identified it as kurstakin, it differed in fatty acid composition (C~15~) when compared to other kurstakin members that contained fatty acids with chain length of C~11~-C~14~, suggesting the lipopeptide fraction (Fr-b) is an isoform of kurstakin. Further, differences in antimicrobial activity spectrum of these peptides attributed to the fatty acid composition differences \[[@B20]\].

A variety of lipopeptides produced by strains *Citrobacter* sp. strain S-3 and *Enterobacter* sp. strain S-11 were identified as lipopeptides belonging to iturin, kurstakin and fengycin with unusual broad spectrum antibacterial activity. It is pertinent to mention that the fraction Fr-e of strains S-3 and S-11, had an identical mass with the lipopeptide reported by Swart and Merwe \[[@B38]\], therefore, we have minimized further attempt to characterize the full sequence as reported \[β-NC~14~NYNQPNS\]. Additionally, identification of C~14~ fatty acid as the lipid content of the fraction Fr-e also confirmed their classification under iturins as they are known to contain a fatty acid chain length of C~14~ to C~16~\[[@B39]\] along with a cyclic peptide of seven amino acids. Cyclic lipopeptide biosurfactants like iturin, mycosubtilin, surfactin and kurstakin are largely produced by species of *Bacillus* exhibiting antimicrobial activity \[[@B12],[@B28]\]. In fact, iturin and fengycin produced by *B. subtilis* are recognized as potential biopharmaceutical agents due to their antimicrobial and biosurfactant properties \[[@B14]\]. Although different types of lipopeptides varied in their amino acid and/or fatty acid composition, they all are usually thermostable, resistant to proteolytic enzymes and inhibits the growth by altering the membrane integrity. Similarly no reduction in antibacterial activity was observed for fraction Fr-e upon exposing it to 100°C temperature for 30 min suggesting it as heat stable. The amino acid composition analysis of highly active lipopeptide fraction (Fr-c) of strain S-3 and S-11 revealed the sequence as R(C17)EOrnYTEVPEYV which corresponds to linearized fengycin B'2, an isoform produced by a *B. subtilis* strain \[[@B40]\]. Among the other lipopeptide fractions, Fr-f (m/z 607.21 Da) and Fr-d (m/z 637.23 Da), produced by strains S-3 and S-11, respectively, showed significant antimicrobial activity, but could not be assigned to any lipopeptide family as their molecular mass did not match with any reported antimicrobial lipopeptides. Other mass ions, except m/z 679 Da, produced by different strains did not show significant antimicrobial activity against any test strain. Although iturins, kurstakins, surfactins and fengycins differed in composition, they followed the same mechanisms such as involving pore formation on bacterial membrane \[[@B41]\] or by other non-specific interactions with the membrane \[[@B42]\] as a result of their antimicrobial activity. Findings of this study, together with the fact that the entire isolated strains belong to *Citrobacter* or *Enterobacter* and antimicrobial lipopeptide production ability, suggests that they are possibly produced by these bacteria as a part of defence mechanism to survive in complex environments.

Conclusions
===========

This is the first report on antibacterial lipopeptides production by strains of *Citrobacter* and *Enterobacter* that are part of the human intestinal flora and frequently observed in food. The lipopeptides are exceedingly useful molecules with potential applications in several biotechnology sectors such as pharmaceutical, cosmetic, preservation of food and dairy products. However, engineering of these molecules is very important for our future needs as the large scale production of antimicrobial lipopeptides is expensive. Therefore, strains like S-3 or S-11 with ability to co-produce different antimicrobial lipopeptides are very useful in biotechnology sector. Increased lipopeptides production by these strains through the optimization of physicochemical parameters or transcriptional regulation of lipopeptide synthetase gene clusters could be future insight for commercial production.

Methods
=======

Isolation of bacteria and identification
----------------------------------------

The bacterial isolates designated as S-3, S-4, S-5, S-6, S-7, S-9, S-10, S-11 and S-12 were isolated from a fecal contaminated soil sample. The soil sample used to isolate the strains was serially diluted and plated on nutrient agar with the following composition (g/l): peptic digest of animal tissue, 5.0; beef extract, 1.5; yeast extract, 1.5; sodium chloride, 5.0; agar 15.0 (pH adjusted to 7.2). Colonies with inhibition zone in their surroundings were selected and streaked on to fresh nutrient agar (NA, HiMedia, India) medium plates. Upon testing their purity all isolates were preserved at -70°C for further studies. Indicator strains used to test the activity of lipopeptides were obtained from Microbial Type Culture Collection and Genebank (MTCC), Chandigarh, India. The test strains were grown on tryptone soya agar (TSA) medium with the following composition (g/l): pancreatic digest of casein, 15.0; papaic digest of soybean meal, 5.0; sodium chloride, 5.0; agar 15.0 and the pH adjusted to 7.2. All isolates producing antimicrobial lipopeptides were tested for phenotypic properties including morphology, physiology and biochemical characteristics using standard procedures. The identity of isolates was also confirmed by using 16S rRNA gene sequence \[[@B43]\] blast search analysis. All 16S rRNA gene sequences of the nearest type strains were downloaded from the NCBI database and aligned using CLUSTAL_W program of MEGA version 5 \[[@B44]\]. The alignment was corrected manually using the BioEdit sequence alignment editor \[[@B45]\]. Pair-wise evolutionary distances were calculated with the Kimura two-parameter \[[@B46]\] and a neighbour-joining phylogenetic tree was constructed using the MEGA version5.0. The stability of phylogenetic tree was assessed by taking 1000 replicates. All sequences have been submitted to EMBL database \[accession nos. HF572835 - HF572843\].

Extraction of lipopeptides
--------------------------

Lipopeptides produced by all strains were isolated from culture supernatant by a combination of acid and solvent extraction procedure \[[@B47]\]. In brief, cells were pellet down from the culture broth by centrifugation (13,000 × g) for 15 min at 4°C. The supernatant pH was adjusted to 2.0 by addition of concentrated HCl and allowed to precipitate at 4°C for 16 h. After centrifugation (13,000 × g) for 20 min at 4°C the precipitate was collected and extracted with methanol by stirring for 2 h. The lipopeptide containing methanol was collected after filtration and vacuum-dried.

Purification of lipopeptides
----------------------------

The lipopeptides extracted were dissolved in methanol and fractionated by reverse phase- HPLC (Agilent 1100 series, CA, USA) with a ZORBAX 300-SB18 column (4.6 mm × 250 mm, particle size 5 μm), at a flow rate of 1 ml/min. The solvent system used was (A) 0.1% aqueous TFA and (B) acetonitrile containing 0.1% TFA. The following gradient of solvent B was used to run the column: 0-60% for 0-45 min, 60-80% for 45-55 min and 80-100% for 55-60 min. All peptides eluted from the column were monitored at 215 nm in a diode array detector and all peaks obtained during HPLC were collected using a fraction collector (GILSON, France) that is coupled with the system. These fractions were concentrated by speed vacuum and tested for their antimicrobial activity. The fractions or peaks that showed antibacterial activity were re-chromatographed in the same column under similar conditions, except solvent B was used as 100% acetonitrile with a gradient of 0-10% for 30 min. The peptide concentration was determined using the RP-HPLC conditions and calibrated with surfactin (Sigma-Aldrich, St. Louis, USA).

Antimicrobial assay and MIC determination
-----------------------------------------

All fractions from the reversed phase HPLC were lyophilized, redissolved in MilliQ water to test their antimicrobial activity against *S. epidermidis* (MTCC435) and *P. aeruginosa* (ATCC27853) in a microtiter plate assay in triplicates. To examine the bacterial growth or killing rate in the presence of different fractions, bacterial cells were grown in 100 μl of Mueller-Hinton broth (MHB, HiMedia, India) supplemented with fixed concentration (10 μg/ml) of each fraction, at 37°C. Growth or killing rates were determined by measuring OD at 600 nm. The OD values were converted into concentration of cells measured in CFU per millilitre (1.0 OD corresponded to 2.16 × 10^8^ CFU/ml). The MIC of selected biosurfactant/lipopeptide was evaluated for strains *S. aureus* (MTCC1430), *M. luteus* (MTCC106) and *S. marcescens* (MTCC 97) along with *P*. *aeruginosa* and *S. epidermidis* by using a microtiter plate dilution assay in triplicates as described earlier \[[@B48]\]. Test strains were grown to logarithmic phase (between 0.3-0.4 OD) under optimal conditions. The lowest concentration inhibiting the growth of test strain without showing any increase in absorption up to 48 h of incubation was considered as MIC.

MALDI-TOF-MS and sequencing
---------------------------

The purified and active lipopeptides were analysed for molecular mass and MS/MS sequencing by using a Voyager time-of-flight mass spectrometer (Applied Biosystems, Foster City, CA, USA). For MS/MS sequencing, the lactone ring present in lipopeptide was cleaved by incubating each peptide with 10% NaOH in methanol at room temperature for 16 h. The cleaved peptide obtained was lyophilized and again extracted with methanol, and allowed for mass spectrometry analysis. Spectra were recorded in the post-source decay (PSD) ion mode as an average of 100 laser shots with a grid voltage of 75%. The reflector voltage was reduced in 25% steps and guide wire was reduced 0.02--0.01% with an extraction delay time of 100 ns.

Fatty acid analysis by GC-MS
----------------------------

To analyze the fatty acid content associated with the lipopeptides, the peptides (5 mg of each) were incubated with 0.5 ml of 6 M HCl at 90°C for 18 h in sealed tubes for acid hydrolysis. The fatty acids were extracted with ether, treated with 0.95 ml methanol and 0.05 ml of 98% H~2~SO~4~ at 65°C for 6 h. Finally, fatty acid methyl esters were obtained with n-hexane extraction and analyzed on GC-MS with a Clarus 500 GC (PerkinElmer, USA). The carrier gas used was helium with a flow rate of 1.0 ml/min. The column temperature was maintained at 120°C for 3 min and thereafter gradually increased (8°C/min) to 260°C.

Statistical analysis
--------------------

The statistical significance of the experimental results was determined using one-way ANOVA followed by Dunnett's test. Values of p\<0.05 were considered statistically significant. Prism version 5.0 was used for all statistical analyses. The results are presented as the mean of triplicates (n=3) ± SD.
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